Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction.

Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction.
复制标题

DOI:
10.1038/bjc.2013.748
复制
发表时间:
2014-01-21
影响因子:
8.8
通讯作者:
Takeyama, H.
Takeyama, H.
中科院分区:
医学1区
文献类型:
--
作者:
Nagasaki, T.;Hara, M.;Nakanishi, H.;Takahashi, H.;Sato, M.;Takeyama, H.

文献摘要

参考文献

被引文献

相似文献

白细胞介素-6(IL-6)在癌症进展中具有重要作用,并且高水平的血浆IL-6与多种癌症的不良预后相关。还报道了肿瘤基质成纤维细胞对于癌症进展中的步骤(例如血管生成)是必需的。很少有报道成纤维细胞的作用和IL-6水平之间的相关性。在这项研究中,我们研究了癌间质成纤维细胞和IL-6之间的相关性,以及IL-6作为人类结肠癌治疗靶点的效用。采用实时荧光定量PCR和ELISA检测成纤维细胞和癌细胞系中IL-6和VEGF的表达水平。在血管生成模型和动物实验中测量抑制IL-6信号传导的抗血管生成作用。我们证明,从结肠癌中分离的基质成纤维细胞产生大量的IL-6,结肠癌细胞增强基质成纤维细胞产生IL-6。此外,IL-6增强成纤维细胞产生VEGF,从而诱导血管生成。在体内,靶向间质组织的抗IL 6受体抗体显示出比靶向异种移植癌细胞的抗IL 6受体抗体更大的抗肿瘤活性。癌间质成纤维细胞是结肠癌中IL-6的重要来源。由活化的成纤维细胞产生的IL-6通过刺激邻近的基质成纤维细胞诱导肿瘤血管生成。IL-6与间质成纤维细胞之间的关系为癌症治疗提供了新的途径。
Interleukin-6 (IL-6) has an important role in cancer progression, and high levels of plasma IL-6 are correlated with a poor prognosis in a variety of cancers. It has also been reported that tumour stromal fibroblasts are necessary for steps in cancer progression, such as angiogenesis. There have been few reports of a correlation between fibroblast actions and IL-6 levels. In this study, we examined the correlation between cancer stromal fibroblasts and IL-6 and the utility of IL-6 as a therapeutic target in human colon cancer. The expression levels of IL-6 and VEGF of fibroblasts and cancer cell lines were evaluated using real-time PCR and ELISA. The anti-angiogenic effect of inhibiting IL-6 signalling was measured in an angiogenesis model and animal experiment. We demonstrate that stromal fibroblasts isolated from colon cancer produced significant amounts of IL-6 and that colon cancer cells enhanced IL-6 production by stromal fibroblasts. Moreover, IL-6 enhanced VEGF production by fibroblasts, thereby inducing angiogenesis. In vivo, anti-IL6 receptor antibody targeting stromal tissue showed greater anti-tumour activity than did anti-IL6 receptor antibody targeting xenografted cancer cells. Cancer stromal fibroblasts were an important source of IL-6 in colon cancer. IL-6 produced by activated fibroblasts induced tumour angiogenesis by stimulating adjacent stromal fibroblasts. The relationship between IL-6 and stromal fibroblasts offers new approaches to cancer therapy.
DOI: 10.1158/0008-5472.can-10-0538
发表时间: 2011-01-15
期刊: Cancer research
影响因子: 11.2
作者:
Liu S;Ginestier C;Ou SJ;Clouthier SG;Patel SH;Monville F;Korkaya H;Heath A;Dutcher J;Kleer CG;Jung Y;Dontu G;Taichman R;Wicha MS
通讯作者: Wicha MS
DOI: 10.1038/sj.onc.1205260
发表时间: 2002-03-21
期刊: ONCOGENE
影响因子: 8
作者:
Niu, GL;Wright, KL;Yu, H
通讯作者: Yu, H
DOI: 10.1155/2011/765624
发表时间: 2011
期刊: Arthritis
影响因子: --
作者:
Hashizume M;Mihara M
通讯作者: Mihara M
IL-6促进U251和T98G细胞系中胶质母细胞瘤细胞侵袭和血管生成
DOI: 10.1007/s11060-010-0158-0
发表时间: 2010-11-01
影响因子: 3.9
作者:
Liu, Qinglin;Li, Gang;Zhang, Jian
通讯作者: Zhang, Jian
DOI: 10.1007/s12307-012-0098-7
发表时间: 2012-04-01
影响因子: --
作者:
Hugo, Honor J.;Lebret, Stephanie;Ackland, M. Leigh
通讯作者: Ackland, M. Leigh